When you hear “minimally invasive thoracic surgery,&rdquo you’re talking about chest operations done through a few small cuts instead of a large incision and rib spreading. Surgeons use cameras and long, specialized instruments to work precisely inside your chest, often with less pain and a faster recovery. But not every lung or chest problem qualifies for this approach, and understanding when it’s used and when it’s not can significantly shape your options.
Minimally invasive thoracic surgery (MITS) is a way to perform chest operations using small incisions instead of a large opening and rib spreading. Typically, the surgeon makes about 1 to 5 cuts between the ribs, each about 1–2 cm (around 1 inch) in length. Through these small openings, the surgeon uses specialized instruments to operate on structures inside the chest, such as the lungs, pleura, or mediastinum.
There are two main approaches:
These operations are performed under general anesthesia, so you're fully asleep and don't feel pain during the procedure.
After surgery, a chest tube is usually placed temporarily to drain air and fluid from the chest cavity and help the lung re-expand.
Minimally invasive thoracic surgery can address a broad range of conditions within the chest, including diseases of the lungs, esophagus, and mediastinum (the central compartment of the thoracic cavity).
For lung disease, minimally invasive techniques are commonly used to remove early-stage lung cancers and selected solitary pulmonary metastases. Depending on the size and location of the lesion, this may involve a wedge resection, segmentectomy, or lobectomy, with video-assisted thoracoscopic surgery (VATS) lobectomy frequently used as a standard approach.
Surgeons also use minimally invasive methods to remove thymic and other mediastinal masses, including performing thymectomy in patients with myasthenia gravis when indicated. In the esophagus, minimally invasive esophagectomy is used for certain cases of esophageal cancer, and minimally invasive approaches are applied to repair hiatal and paraesophageal hernias.
Additional conditions treated with minimally invasive thoracic surgery include spontaneous or recurrent pneumothorax, various pleural diseases (such as pleural effusions or pleural thickening), thoracic outlet syndrome, and severe hyperhidrosis. These procedures aim to achieve effective treatment while potentially reducing postoperative pain, length of hospital stay, and recovery time compared with traditional open surgery, when appropriate for the patient’s condition.
As you consider which thoracic conditions can be treated through small incisions, it's also important to understand how these methods compare with a traditional thoracotomy.
Minimally invasive thoracic surgery typically avoids the large chest incision and rib spreading used in open surgery. Instead, it uses several small (about 1–2 cm) incisions, which are generally associated with less postoperative pain and a lower requirement for opioid pain medication.
Studies also indicate that minimally invasive approaches can lead to reduced blood loss, fewer transfusions, and a lower risk of wound-related complications and infections. Many patients are discharged from the hospital earlier and recover strength and lung function within approximately 2–3 weeks, although recovery times vary.
For early-stage lung cancer, video-assisted thoracoscopic (VATS) lobectomy has been shown in multiple series to provide cancer control comparable to thoracotomy, while often resulting in fewer postoperative complications.
Choosing between video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracic surgery involves understanding that both are minimally invasive approaches using small incisions and a camera, but they differ in how the surgeon operates and what the technology allows.
In VATS, the surgeon stands at the patient’s side and uses a thoracoscope (a thin camera) and long, rigid instruments inserted through 2–4 small incisions in the chest. The view is typically two-dimensional, and the instruments have limited degrees of motion. This approach is well-established and widely used, particularly for early-stage lung cancer and other common thoracic procedures.
In robotic-assisted thoracic surgery, the surgeon sits at a console away from the operating table and controls robotic arms that hold a 3D high-definition camera and wristed instruments. These instruments can bend and rotate in more directions than standard VATS tools, which may allow more precise movements in confined spaces. However, robotic systems usually require additional setup time and specialized equipment and training, which can affect cost and operating room logistics.
Current evidence suggests that both VATS and robotic-assisted surgery can achieve similar outcomes in terms of safety, length of hospital stay, and cancer control for many procedures. VATS is often considered the standard minimally invasive option for early lung cancer, while robotic surgery may offer technical advantages in selected cases, such as complex resections or operations in difficult-to-reach areas. The choice between them typically depends on the specifics of the disease, the surgeon’s experience with each technique, and the resources available at the treating hospital.
You may be a candidate for VATS or robotic lung surgery if your diagnosis and overall health allow the procedure to be done safely and effectively. These approaches are most often used for:
To determine suitability, your surgeon reviews:
Factors such as prior chest surgery, dense scar tissue (adhesions), and very large or centrally located tumors may reduce the feasibility of a minimally invasive approach or increase the likelihood of needing to convert to an open operation during surgery.
During minimally invasive thoracic surgery, you receive general anesthesia so you're fully asleep and don't feel pain. You're then positioned on your side, and a breathing tube is placed into your airway. This allows the anesthesia team to deflate one lung, creating space in the chest so the surgeon can operate safely.
The surgeon then makes one to five small incisions, usually about 1–2 centimeters each, between the ribs. In video-assisted thoracoscopic surgery (VATS), a thin camera called a thoracoscope is inserted through one incision, while specialized instruments are inserted through the others. The surgeon views the surgical area on video monitors and can perform procedures such as wedge resection, segmentectomy, or lobectomy through these small openings.
In robotic-assisted thoracic surgery, similar small incisions are used, but the instruments and camera are attached to robotic arms. The surgeon operates from a nearby console, controlling a 3D camera and wristed instruments that allow precise movements inside the chest.
At the end of either type of procedure, the surgeon typically places a chest tube to drain air and fluid from the chest cavity and help the lung re-expand. The small incisions are then closed with sutures or staples.
As you prepare for minimally invasive thoracic surgery, you'll move through several defined stages designed to maintain safety and support recovery.
Before surgery, you'll meet with your surgical and anesthesia teams, review your medical history and current medications, and have a physical examination. You may undergo tests such as blood work, imaging studies (for example, chest X‑ray or CT scan), and lung-function tests to assess your ability to tolerate the procedure. You'll also receive instructions about fasting, adjusting certain medications, and what to expect on the day of surgery.
In the operating room, you'll receive general anesthesia so you're fully asleep and don't feel pain. An endotracheal tube is placed to support your breathing and allow one-lung ventilation, which gives the surgeon better access to the operative side of the chest.
During the operation, you're typically positioned on your side. The surgeon works through one to several small incisions using video-assisted thoracoscopic surgery (VATS) or a robotic-assisted system, depending on your specific case and the surgeon’s assessment. Instruments and a camera are inserted through these incisions to perform the necessary procedure while minimizing trauma to the chest wall.
After surgery, a chest tube is usually left in place to drain air and fluid and to help the lung re-expand. This tube is generally removed once drainage decreases and imaging confirms adequate lung expansion, often within a few days, although the exact timing varies by patient and procedure. Pain control, breathing exercises, and early mobilization are important aspects of recovery.
Most patients experience gradual improvement in strength and breathing capacity over several weeks, but the total recovery time depends on factors such as the type of surgery, overall health, and pre-existing lung function.
Even though minimally invasive thoracic surgery usually results in less pain and faster recovery than open surgery, it still involves important risks and side effects. Potential complications include infection, bleeding, heart rhythm disturbances (arrhythmias), pneumonia, venous thromboembolism (blood clots in the veins), and significant postoperative pain.
An air leak from the lung can persist longer than expected. To monitor and manage air and fluid drainage from the chest, surgeons typically place one or more chest tubes after the operation. In some cases, robotic-assisted procedures can involve longer anesthesia times, which may increase risk for individuals with underlying heart or lung disease.
During the operation, the surgeon may need to convert from a minimally invasive approach to an open thoracotomy. Common reasons include difficulty controlling bleeding, dense scar tissue (adhesions), limited visibility, complex tumor anatomy, or any concern that continuing minimally invasively could compromise safety or outcomes.
Although minimally invasive thoracic surgery can shorten recovery time and reduce postoperative pain, outcomes still depend significantly on the surgical team and the institution where the procedure is performed.
When evaluating a program, consider centers with a high volume of minimally invasive cases, particularly video‑assisted thoracoscopic surgery (VATS) lobectomies, and substantial experience in treating lung cancer.
Ask about your surgeon’s background and training. It can be useful to know whether they're involved in training residents or fellows, lead advanced VATS or thoracic courses, or routinely use robotic platforms such as the da Vinci system. These factors may indicate familiarity with current techniques and technologies.
Confirm that the program has comprehensive multidisciplinary support, including thoracic anesthesia, pulmonary medicine, interventional bronchoscopy, endobronchial ultrasound (EBUS), and a structured follow‑up process. Access to these services can be important for accurate diagnosis, perioperative management, and long‑term monitoring.
In addition, review the program’s use of technology, such as 3D imaging, robotic systems, and experience with complex procedures like segmentectomy or esophagectomy, and ask about patient‑centered outcomes. Relevant metrics include average hospital length of stay, duration of chest tube placement, rates of conversion from minimally invasive to open surgery, complication and readmission rates, and availability of telehealth for pre‑ and postoperative visits. These data can help you compare programs in a more objective way.
Minimally invasive thoracic surgery lets you get effective treatment through smaller incisions, less pain, and a faster recovery than a traditional thoracotomy. By understanding your options, like VATS vs. robotic, benefits, risks, and what to expect, you’re better prepared to make informed choices. Talk openly with your thoracic surgeon about your goals, overall health, and concerns so you can decide together if this approach is the safest and most effective option for you.